
    
      This is a mechanistic study evaluating in a cross-over design the effects of Itopride
      hydrochloride.

      The primary objective of this study is to evaluate the acute effects of itopride
      hydrochloride (200 mg three times daily) on gastric emptying of solid and liquid meal
      components in patients with type 1 and type 2 diabetes mellitus. Secondary objectives are to
      evaluate the effects of itopride hydrochloride on the glycaemic response to a meal,
      "meal-related" upper gastrointestinal symptoms and intragastric meal distribution.
    
  